TABLE 1.
Baseline and demographic characteristics of patients
| Characteristics | |
|---|---|
| Mean age ± SD (range) | 62±10.5 (21–89) |
| Age in years, n (%) | |
| 45 | 45 (5.4) |
| 46–64 | 455 (54.4) |
| 65–74 | 245 (29.3) |
| ≤75 | 89 (10.6) |
| Sex, n (%) | |
| Male | 523 (62.5) |
| Female | 313 (37.4) |
| 10-year coronary artery disease risk, n (%) | |
| Mild (≤10%) | 20 (2.4) |
| Moderate (11% – 19%) | 40 (4.8) |
| High (≥20%) | 777 (92.8) |
|
Comorbidity and risk factor profile | |
| Smoking status, n (%) | |
| Current smoker | 191 (22.8) |
| Past smoker | 268 (32.0) |
| Nonsmoker | 375 (44.8) |
| Hypertension, n (%) | 432 (51.6) |
| Diabetes mellitus (type 2), n (%) | 358 (42.8) |
| The metabolic syndrome, n (%) | 408 (48.7) |
| Diabetes mellitus and the metabolic syndrome, n (%) | 244 (29.2) |
| Coronary artery disease, n (%) | 388 (46.3) |
| Cerebrovascular disease, n (%) | 75 (9.0) |
| Peripheral vascular disease, n (%) | 78 (9.3) |
| Chronic kidney disease, n (%) | 15 (1.8) |
| Family history of cardiovascular disease, n (%) | 504 (60.2) |
| Menopausal status, n (%) (n=313) | |
| Premenopause | 22 (7.0) |
| Menopause | 291 (93.0) |
| Use of hormone replacement therapy | 54 (17.3) |